SEC Filings

10-Q
AMSURG CORP filed this Form 10-Q on 08/14/1997
Entire Document
 
<PAGE>   4

                                  AMSURG CORP.
                      CONSOLIDATED STATEMENTS OF CASH FLOWS



<TABLE>
<CAPTION>
                                                                                    SIX MONTHS ENDED JUNE 30,
                                                                                      1997             1996
                                                                                   ------------     -----------
<S>                                                                                <C>              <C>
Cash flows from operating activities:
    Net income (loss)                                                              $ (1,217,610)    $   717,654
       Income tax expense                                                               736,000         477,000
       Minority interest                                                              4,233,940       2,455,823
                                                                                   ------------     -----------

    Income before minority interest and income taxes                                  3,752,330       3,650,477
    Noncash expense, revenues, losses and gains included in net income (loss):
       Depreciation and amortization                                                  2,222,941       1,332,173
       Impairment loss                                                                2,321,168            --
       Increase in working capital items                                               (458,577)       (626,843)
       Other noncash transactions                                                        30,177          58,334
                                                                                   ------------     -----------

                                                                                      7,868,039       4,414,141
    Increase in other assets                                                           (366,909)        (80,731)
    Income taxes paid                                                                  (659,476)       (647,500)
                                                                                   ------------     -----------

           Net cash flows provided by operating activities                            6,841,654       3,685,910
                                                                                   ------------     -----------

Cash flows from investing activities:
    Acquisition of majority interest in surgery centers and physician practices      (6,954,262)     (3,760,728)
    Acquisition of property and equipment                                            (5,165,210)     (1,652,445)
    Decrease in long-term receivables                                                    19,717          34,020
                                                                                   ------------     -----------

           Net cash flows used in investing activities                              (12,099,755)     (5,379,153)
                                                                                   ------------     -----------

Cash flows from financing activities:
    Additions to long-term debt                                                       9,094,698       2,895,000
    Payments on long-term debt                                                       (1,446,546)     (1,443,701)
    Distributions to minority partners                                               (4,074,328)     (2,345,112)
    Issuance of common stock, net of issuance costs                                     383,171         306,281
    Increase in financing costs                                                         (64,526)         (6,609)
    Capital contributions by minority partners                                        1,302,923         518,180
                                                                                   ------------     -----------

           Net cash flows provided by (used in) financing activities                  5,195,392         (75,961)
                                                                                   ------------     -----------

Net decrease in cash and cash equivalents                                               (62,709)     (1,769,204)
Cash and cash equivalents, beginning of period                                        3,192,408       3,469,661
                                                                                   ------------     -----------

Cash and cash equivalents, end of period                                           $  3,129,699     $ 1,700,457
                                                                                   ============     ===========
</TABLE>









See accompanying notes to the consolidated financial statements




                                        4